Advertisement

Topics

Arcus Biosciences closes $107M Series C round as industry hunts for blockbuster immunotherapy combinations

16:40 EST 13 Nov 2017 | MedCity News

Money bag icon on blackboard with hand

New research by the Cancer Research Institute puts the number of industry-wide combination trials at 1,105.

Original Article: Arcus Biosciences closes $107M Series C round as industry hunts for blockbuster immunotherapy combinations

NEXT ARTICLE

More From BioPortfolio on "Arcus Biosciences closes $107M Series C round as industry hunts for blockbuster immunotherapy combinations"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...